NCT04596033 2022-07-15TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell TherapyGenocea Biosciences, Inc.Phase 1 Terminated49 enrolled
NCT00157196 2015-08-18Safety Study of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III DiseaseMerck KGaA, Darmstadt, GermanyPhase 2 Completed22 enrolled 6 charts